For decades clinicians have measured four traditional vital signs: temperature, heart rate, respiratory rate and blood pressure, because they are rapid, objective indicators of physiologic function. Increasingly, expert bodies and researchers argue that the menstrual cycle should be treated as a fifth vital sign for people of reproductive age: a routinely recorded, clinically meaningful measure that reflects not only reproductive health but wider endocrine, metabolic and psychosocial wellbeing.
What is the menstrual cycle?
The menstrual cycle is a repeating endocrine and endometrial process that, in ovulatory cycles, prepares the uterus for pregnancy and is regulated by the hypothalamic-pituitary-ovarian axis. It is normally described in phases:
- Menstrual (bleeding) phase: shedding of the functional layer of endometrium (day 1 = first day of bleeding).
- Follicular (proliferative) phase: follicle growth under follicle-stimulating hormone and rising estradiol.
Ovulation: luteinizing hormone surge and release of an oocyte. - Luteal (secretory) phase: corpus luteum produces progesterone; if pregnancy does not occur, progesterone falls and menses begins.
Cycle length is conventionally considered normal when approximately 21–35 days (adult ranges vary in some large studies 24–38 days; adolescents may have wider variation initially). Bleeding typically lasts 2–7 days. Persistent deviations from these parameters (short or long cycles, heavy or prolonged bleeding, amenorrhea, or severe cyclical pain) warrant evaluation.
Why call it a “vital sign”?
A vital sign is valuable because it is simple to collect and gives rapid insight into health. Like the four cardinal vital signs, menstrual characteristics (cycle length, regularity, bleeding amount/duration, and cyclical symptoms) provide a window on multiple organ systems:
- Endocrine/metabolic disease: thyroid disorders, hyperprolactinemia and metabolic syndrome / polycystic ovary syndrome (PCOS) commonly present with menstrual irregularities.
- Energy availability and bone health: functional hypothalamic amenorrhea (from low energy availability, stress, excessive exercise) indicates low energy availability, which has well-known impacts on bone health and long-term well-being.
- Long-term risk predictor: Cycle irregularities (especially long or highly variable cycles) have been linked to future risks of cardiovascular disease. A large prospective study found that women with irregular or long cycles had a higher chance of developing CVD later in life.
- Mental health and quality of life: cyclical mood and somatic symptoms (e.g., premenstrual disorders) predict functional impairment and often coexist with psychiatric diagnoses.
- Cyclic impact on other physiologic systems: Research shows that not only do traditional vital signs (temperature, blood pressure) shift across the menstrual cycle, but inflammatory markers and immune factors also fluctuate.
Recognizing cycle features as routinely recorded clinical data helps detect disease earlier, guide investigations (e.g., endocrine tests, imaging), and monitor treatment responses. Expert organizations, notably the American College of Obstetricians and Gynecologists (ACOG) and pediatric bodies, recommend including menstrual history as part of routine assessment, particularly in adolescents.
Evidence base and population data
Large-scale analyses using menstrual-tracking apps and cohort studies have documented real-world cycle variability and shown that deviations are common and clinically informative. For example, population studies have reaffirmed typical cycle length ranges and quantified the frequency of irregular cycles and heavy bleeding, highlighting that menstrual abnormalities affect a substantial minority and are under-reported in routine care.
A recent comprehensive review argues that menstrual cycle characteristics should be documented from menarche through to menopause and treated as a vital sign, pointing out how cycle patterns reflect health and disease risk.That review also summarizes tools for cycle tracking, clinical guidelines, and associations with long-term outcomes (e.g., cancer risk, metabolic disease).
Clinical Guidelines
Professional bodies back up this concept. The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion No. 651 recommends that clinicians assess cycle length, regularity, bleeding, and symptoms in adolescents as part of routine health checks. Earlier ACOG guidance (2006) also emphasized that abnormal bleeding patterns should prompt investigation.
A newer perspective article in the Hong Kong Journal of Gynaecology, Obstetrics and Midwifery further reinforces this idea, noting that menstrual complaints (pain, bleeding, irregular cycles) are frequently under-reported but often have significant health implications.
Practical clinical thresholds (what to record and when to investigate)
Clinically useful menstrual data to record:
- Cycle length (days from day 1 to day 1) and variation (difference between shortest and longest cycles in a year).
- Bleeding duration and subjective flow (light/moderate/heavy; quantify if possible, e.g., number of pads/tampons or passage of clots).
- Pain severity (impact on daily activities), intermenstrual bleeding, and amenorrhea.
- Contraceptive or hormonal therapy use and recent changes.
Triggers for evaluation (not exhaustive): persistent cycle length <21 days or >35–38 days (adults), bleeding >7–8 days, heavy bleeding that causes anemia or activity limitation, secondary amenorrhea (no menses for ≥3 months in someone previously regular), or severe dysmenorrhea. Guidelines from FIGO, ACOG and pediatric committees provide stepwise evaluation algorithms.
What should patients know?
- Tracking gives you valuable information: patterns over time often reveal more than a single “bad” month.
- Changes in your cycle: either in regularity, bleeding volume, or pain are not always “just normal”. They may reflect underlying health issues.
- Sharing tracked data with your clinician can improve diagnosis, help tailor treatment, and guide preventive care.
Recognizing the menstrual cycle as a fifth vital sign isn’t just a catchy idea, it’s backed by strong research and leading medical organizations. Your cycle’s timing, flow, and symptoms can reveal a lot about your overall health, from hormones and metabolism to heart and reproductive well-being.
When clinicians make menstrual history a routine part of care, they can spot concerns earlier and offer more personalized, effective support. And when patients track their cycles, they gain valuable insight into their bodies and a clearer way to communicate with their healthcare providers.
In short, menstrual health deserves the same attention and respect as any other vital sign. Normalizing this conversation helps everyone receive better, more informed care.
